The diagnostic accuracy of digital PCR, ARMS and NGS for detecting KRAS mutation in cell-free DNA of patients with colorectal cancer: A protocol for systematic review and meta-analysis

The diagnostic accuracy of digital PCR, ARMS and NGS for detecting KRAS mutation in cell-free DNA of patients with colorectal cancer: A protocol for systematic review and meta-analysis

Introduction: Cetuximab and panitumumab has been used clinically to treat metastatic colorectal cancer for over 15 years. Before the treatment is given, it is necessary to determine the KRAS mutation status because it would lead to drug resistance. tumor tissue sample is traditionally used for genotyping of cancer. In recent years, the biopsy sample liquid has been intensively investigated as a substitute for tumor tissue samples for non-invasive and better presentation of tumor heterogeneity.

The purpose of this study was to systematically summarize the accuracy of the measurement of KRAS mutations in colorectal cancer using the cell-free DNA in the sample liquid biopsy, the tumor tissue samples as reference (gold standard).
Methods and analysis: We will find literature in the following databases: Pubmed, Embase, and the Cochrane Library. systemic review and meta-analysis will be conducted to summarize the accuracy of the measurement of KRAS mutations in colorectal cancer using biopsy samples of liquid and subgroup analyzes will be performed on different testing platforms, and in colorectal cancer metastatic and non-metastatic.
Timeline: The research will begin on June 1, 2020, and is expected to be completed date of 1 November 2020.


Ethics and deployment: Ethics approval will not be required because the data obtained and analyzed in this study will not be in each patient. The results of the research will be disseminated as an official publication in peer-reviewed

A PCR-based NGS protocol for whole genome sequencing of West Nile virus 2 direct descendant of biological specimens.

Lineage 2 West Nile virus (WNV) strain has been involved in a severe outbreak of encephalitis in humans and equines which are in Europe. WNV molecular characterization is important for the development of diagnostic tests, and to obtain molecular information, which is necessary for epidemiological investigations in areas at risk of virus transmission.

For whole-genome sequencing of strains of WNV lineage 2, directly from biological specimens, PCR-based NGS protocol developed. This method is applied to the WNV-positive specimens were obtained from animals, human and mosquito hosts in Greece. Outcomes of the application shows that, even in the case of a low viral titers, developed PCR-based NGS approach capable of providing whole genome sequence of strain lineage 2 WNV.

The diagnostic accuracy of digital PCR, ARMS and NGS for detecting KRAS mutation in cell-free DNA of patients with colorectal cancer: A protocol for systematic review and meta-analysis
The diagnostic accuracy of digital PCR, ARMS and NGS for detecting KRAS mutation in cell-free DNA of patients with colorectal cancer: A protocol for systematic review and meta-analysis

The latest trends in molecular diagnostics yeast infection: PCR for NGS.

The incidence of opportunistic yeast infections in humans has increased in recent years. These infections are difficult to treat and diagnose, partly because the large number and wide variety of species that can be underlying infection.

Moreover, resistance to one or more of antifungal drugs in a strain that infects more and more reported, severely limiting therapeutic options and to show the need for rapid detection of infecting agents and the profile of its drug susceptibility.

Current methods for species identification of constraints and shortage of sensitivity and specificity were satisfactory, and often require a previous culture of the infecting agent, which delays diagnosis.

Recently developed high-throughput technologies such as next-generation sequencing or proteomics opens a completely new way to diagnose more sensitive, accurate and rapid pathogenic yeast. These approaches are the focus of intensive research, but the translation to the clinic needed to overcome important challenges. In this review, we provide an overview of existing approaches and recently appeared which can be used in the identification of the yeast pathogens and their drug resistance profile.

CD79B, Sf9

pro-2404 2µg
EUR 60
Description: Recombinant Human CD79B, Sf9

CD79B siRNA

20-abx911073
  • Ask for price
  • Ask for price
  • 15 nmol
  • 30 nmol

CD79B siRNA

20-abx911074
  • Ask for price
  • Ask for price
  • 15 nmol
  • 30 nmol

Cd79b (untagged ORF) - Rat Cd79b molecule, immunoglobulin-associated beta (Cd79b), (10 ug)

RN207564 10 µg Ask for price

CD79B Protein

20-abx260988
  • Ask for price
  • Ask for price
  • Ask for price
  • 1 mg
  • 20 ug
  • 5 ug

CD79B Protein

abx260988-10g 10 µg
EUR 325

CD79B Protein

abx260988-2g 2 µg
EUR 225

CD79b antibody

10R-CD79baHU 100 ug
EUR 179
Description: Mouse monoclonal CD79b antibody

CD79b antibody

10R-CD79bbMS 500 ug
EUR 385
Description: Hamster monoclonal CD79b antibody

CD79B Antibody

32563 100ul
EUR 439

CD79B Antibody

32563-100ul 100ul
EUR 302.4

CD79B Antibody

E10-31452 100ul
EUR 225
Description: Available in various conjugation types.

CD79B Antibody

E11-184649 100ug/100ul
EUR 225
Description: Available in various conjugation types.

CD79b Antibody

F44972-0.08ML 0.08 ml
EUR 140.25
Description: The B lymphocyte antigen receptor is a multimeric complex that includes the antigen-specific component, surface immunoglobulin (Ig). Surface Ig non-covalently associates with two other proteins, Ig-alpha and Ig-beta, which are necessary for expression and function of the B-cell antigen receptor. This gene encodes the Ig-beta protein of the B-cell antigen component. Alternatively spliced transcript variants encoding different isoforms have been described.

CD79b Antibody

F44972-0.4ML 0.4 ml
EUR 322.15
Description: The B lymphocyte antigen receptor is a multimeric complex that includes the antigen-specific component, surface immunoglobulin (Ig). Surface Ig non-covalently associates with two other proteins, Ig-alpha and Ig-beta, which are necessary for expression and function of the B-cell antigen receptor. This gene encodes the Ig-beta protein of the B-cell antigen component. Alternatively spliced transcript variants encoding different isoforms have been described.

CD79b Antibody

E38PA3830 100ul
EUR 225
Description: Available in various conjugation types.

CD79B Antibody

E92033 100ul
EUR 255
Description: Available in various conjugation types.

CD79b Antibody

GWB-49F5BF 0.1 mg Ask for price

CD79B Antibody

DF6767 200ul
EUR 420

CD79B Antibody

AF4649 200ul
EUR 540

CD79B Antibody

AF4649-100ul 100ul
EUR 350

CD79B Antibody

AF4649-200ul 200ul
EUR 450

CD79B Antibody

AF4649-50ul 50ul
EUR 250

CD79B Antibody

CSB-PA004958KA01HU- each
EUR 402
Description: A polyclonal antibody against CD79B. Recognizes CD79B from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:2000, IHC:1:50-1:200

CD79B Antibody

CSB-PA004958KA01HU-100ul 100ul
EUR 466.8
Description: A polyclonal antibody against CD79B. Recognizes CD79B from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:2000, IHC:1:50-1:200

CD79B Antibody

1-CSB-PA004958LA01HU
  • Ask for price
  • Ask for price
  • 100ug
  • 50ug
Description: A polyclonal antibody against CD79B. Recognizes CD79B from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IF; Recommended dilution: IF:1:50-1:200

CD79B Antibody

1-CSB-PA005233
  • Ask for price
  • Ask for price
  • 100ug
  • 50ug
Description: A polyclonal antibody against CD79B. Recognizes CD79B from Human. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/20000

CD79B Antibody

ABD6767 100 ug
EUR 525.6

CD79b Antibody

RQ5654 100 ug
EUR 356.15
Description: CD79b molecule, immunoglobulin-associated beta, also known as CD79B (Cluster of Differentiation 79B), is a human gene. By fluorescence in situ hybridization, It is mapped to 17q23.3. The CD79B protein together with the related CD79A protein, forms a dimer associated with membrane bound immunoglobulin in B-cells, thus forming the B-cell antigen receptor (BCR) which is a multimeric complex that includes the antigen-specific component, surface immunoglobulin (Ig). CD79b also can enhances phosphorylation of CD79A, possibly by recruiting kinases which phosphorylate CD79A or by recruiting proteins which bind to CD79A and protect it from dephosphorylation.

CD79b Antibody

GWB-7F7827 0.2 mg Ask for price

CD79b Antibody

GWB-BCA369 0.02 mg Ask for price

CD79b Antibody

R31586 100 ug
EUR 356.15
Description: Cluster of Differentiation 79b, is a human gene mapped to 17q23.3. The CD79b protein together with the relatedCD79aprotein, forms a dimer associated with membrane bound immunoglobulin in B-cells, thus forming the B-cell antigen receptor (BCR) which is a multimeric complex that includes the antigen-specific component, surface immunoglobulin (Ig). CD79b also enhances phosphorylation of CD79a, possibly by recruiting kinases, or by recruiting proteins which bind to CD79a and protect it from dephosphorylation.

CD79b Antibody

V8930-100UG 100ug
EUR 349.3
Description: The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V8930-20UG 20ug
EUR 153.3
Description: The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V8930SAF-100UG 100ug
EUR 349.3
Description: The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V9128-100UG 100ug
EUR 349.3
Description: CD79 (also designated Ig chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V9128-20UG 20ug
EUR 153.3
Description: CD79 (also designated Ig chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V9128SAF-100UG 100ug
EUR 349.3
Description: CD79 (also designated Ig chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V3804-100UG 100 ug
EUR 424.15
Description: CD79 (also designated Ig alpha/Ig beta) is a heterodimer composed of alpha chains, designated CD79A or MB-1, and beta chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V3804-20UG 20 ug
EUR 186.15
Description: CD79 (also designated Ig alpha/Ig beta) is a heterodimer composed of alpha chains, designated CD79A or MB-1, and beta chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V3804SAF-100UG 100 ug
EUR 424.15
Description: CD79 (also designated Ig alpha/Ig beta) is a heterodimer composed of alpha chains, designated CD79A or MB-1, and beta chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V3806-100UG 100 ug
EUR 424.15
Description: CD79 (also designated Ig alpha/Ig beta) is a heterodimer composed of alpha chains, designated CD79A or MB-1, and beta chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V3806-20UG 20 ug
EUR 186.15
Description: CD79 (also designated Ig alpha/Ig beta) is a heterodimer composed of alpha chains, designated CD79A or MB-1, and beta chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V3806SAF-100UG 100 ug
EUR 424.15
Description: CD79 (also designated Ig alpha/Ig beta) is a heterodimer composed of alpha chains, designated CD79A or MB-1, and beta chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V3810-100UG 100 ug
EUR 424.15
Description: Required in cooperation with CD79A for initiation of the signal transduction cascade activated by the B-cell antigen receptor complex (BCR) which leads to internalization of the complex, trafficking to late endosomes and antigen presentation. Enhances phosphorylation of CD79A, possibly by recruiting kinases which phosphorylate CD79A or by recruiting proteins which bind to CD79A and protect it from dephosphorylation. [UniProt]

CD79b Antibody

V3810-20UG 20 ug
EUR 186.15
Description: Required in cooperation with CD79A for initiation of the signal transduction cascade activated by the B-cell antigen receptor complex (BCR) which leads to internalization of the complex, trafficking to late endosomes and antigen presentation. Enhances phosphorylation of CD79A, possibly by recruiting kinases which phosphorylate CD79A or by recruiting proteins which bind to CD79A and protect it from dephosphorylation. [UniProt]

CD79b Antibody

V3810SAF-100UG 100 ug
EUR 424.15
Description: Required in cooperation with CD79A for initiation of the signal transduction cascade activated by the B-cell antigen receptor complex (BCR) which leads to internalization of the complex, trafficking to late endosomes and antigen presentation. Enhances phosphorylation of CD79A, possibly by recruiting kinases which phosphorylate CD79A or by recruiting proteins which bind to CD79A and protect it from dephosphorylation. [UniProt]

CD79b Antibody

V3956-100UG 100 ug
EUR 349.3
Description: CD79 (also designated Ig alpha/Ig beta) is a heterodimer composed of alpha chains, designated CD79A or MB-1, and beta chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V3956-20UG 20 ug
EUR 153.3
Description: CD79 (also designated Ig alpha/Ig beta) is a heterodimer composed of alpha chains, designated CD79A or MB-1, and beta chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V3956SAF-100UG 100 ug
EUR 349.3
Description: CD79 (also designated Ig alpha/Ig beta) is a heterodimer composed of alpha chains, designated CD79A or MB-1, and beta chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V7631-100UG 100 ug
EUR 349.3
Description: CD79 (also designated Ig chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V7631-20UG 20 ug
EUR 153.3
Description: CD79 (also designated Ig chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V7631SAF-100UG 100 ug
EUR 349.3
Description: CD79 (also designated Ig chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V8265-100UG 100 ug
EUR 424.15
Description: CD79 (also designated Ig chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V8265-20UG 20 ug
EUR 186.15
Description: CD79 (also designated Ig chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V8265SAF-100UG 100 ug
EUR 424.15
Description: CD79 (also designated Ig chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V8457-100UG 100 ug
EUR 424.15
Description: CD79 (also designated Ig chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V8457-20UG 20 ug
EUR 186.15
Description: CD79 (also designated Ig chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79b Antibody

V8457SAF-100UG 100 ug
EUR 424.15
Description: CD79 (also designated Ig chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.

CD79B (untagged)-Human CD79b molecule, immunoglobulin-associated beta (CD79B), transcript variant 1

SC122570 10 µg Ask for price

CD79B (untagged)-Human CD79b molecule, immunoglobulin-associated beta (CD79B), transcript variant 2

SC304941 10 µg Ask for price

CD79B (untagged)-Human CD79b molecule, immunoglobulin-associated beta (CD79B), transcript variant 3

SC311082 10 µg Ask for price

CD79B (untagged)-Human CD79b molecule, immunoglobulin-associated beta (CD79B), transcript variant 3

SC321002 10 µg Ask for price

Lenti ORF particles, Cd79b (GFP-tagged) - Mouse CD79B antigen (Cd79b), 200ul, >10^7 TU/mL

MR202725L4V 200 µl Ask for price

CD79B (GFP-tagged) - Human CD79b molecule, immunoglobulin-associated beta (CD79B), transcript variant 1

RG215340 10 µg Ask for price

CD79B (GFP-tagged) - Human CD79b molecule, immunoglobulin-associated beta (CD79B), transcript variant 3

RG200665 10 µg Ask for price

CD79B (GFP-tagged) - Human CD79b molecule, immunoglobulin-associated beta (CD79B), transcript variant 2

RG217693 10 µg Ask for price

Cd79b (Myc-DDK-tagged ORF) - Rat Cd79b molecule, immunoglobulin-associated beta (Cd79b), (10 ug)

RR207564 10 µg Ask for price

Lenti ORF particles, Cd79b (Myc-DDK-tagged) - Mouse CD79B antigen (Cd79b), 200ul, >10^7 TU/mL

MR202725L3V 200 µl Ask for price

CD79B (Myc-DDK-tagged)-Human CD79b molecule, immunoglobulin-associated beta (CD79B), transcript variant 3

RC200665 10 µg Ask for price

CD79B (Myc-DDK-tagged)-Human CD79b molecule, immunoglobulin-associated beta (CD79B), transcript variant 2

RC217693 10 µg Ask for price

CD79B (Myc-DDK-tagged)-Human CD79b molecule, immunoglobulin-associated beta (CD79B), transcript variant 1

RC215340 10 µg Ask for price

CD79b Rabbit pAb

E2251516 100ul
EUR 225
Description: Available in various conjugation types.

CD79B Rabbit pAb

E2382394 100ul
EUR 225
Description: Available in various conjugation types.

CD79B Rabbit pAb

E2382681 100ul
EUR 225
Description: Available in various conjugation types.

CD79B Rabbit mAb

A4362 20 μL
EUR 778.7
Description: Recombinant fusion protein containing a sequence corresponding to amino acids 1301-1580 of human Gli3 (P10071).

CD79B Rabbit pAb

A2033-100ul 100 ul
EUR 369.6

CD79B Rabbit pAb

A2033-200ul 200 ul
EUR 550.8

CD79B Rabbit pAb

A2033-20ul 20 ul
EUR 219.6

CD79B Rabbit pAb

A2033-50ul 50 ul
EUR 267.6

CD79B Rabbit mAb

A21224 500μL
EUR 213.2
Description: A synthetic peptide corresponding to a sequence within amino acids 630-647 of human LIM kinase 1(LIMK1)(NP_002305.1).

CD79B Rabbit mAb

A23790 100μL
EUR 213.2
Description: Recombinant fusion protein containing a sequence corresponding to amino acids 2645-2813 of human von Willebrand factor (VWF) (NP_000543.3).

CD79B Rabbit mAb

56362 100ul
EUR 339

CD79b Rabbit mAb

56964 100ul
EUR 339

CD79b Rabbit mAb

E2R382394 100ul
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

CD79b antibody (PE)

61R-1273 100 tests
EUR 489
Description: Mouse monoclonal CD79b antibody (PE)

CD79b antibody (PE)

61R-CD79bbMSPE 100 ug
EUR 299
Description: Hamster monoclonal CD79b antibody (PE)

CD79b Antibody (PE)

GWB-BCEFBD 100 TESTS Ask for price

CD79B Antibody (HRP)

20-abx312629
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

CD79b Antibody (RPE)

GWB-FF12E0 100 TESTS Ask for price

CD79b antibody (FITC)

61R-1107 100 tests
EUR 547
Description: Mouse monoclonal CD79b antibody (FITC)

CD79b antibody (FITC)

61R-CD79bbMSFT 500 ug
EUR 477
Description: Hamster monoclonal CD79b antibody (FITC)

CD79b Antibody (FITC)

GWB-184296 0.1 mg Ask for price

CD79B Antibody (FITC)

20-abx312630
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

CD79b Antibody (FITC)

abx139338-100tests 100 tests
EUR 510

Human CD79B Antibody

32245-05111 150 ug
EUR 215

Mouse CD79b Antibody

GWB-1453A2 0.1 mg Ask for price

Mouse CD79b Antibody

GWB-4F03B6 0.2 mg Ask for price

Mouse CD79b Antibody

GWB-AA6669 0.25 mg Ask for price

Mouse CD79b Antibody

GWB-674A15 0.025 mg Ask for price

Mouse CD79b Antibody

GWB-CA3480 0.025 mg Ask for price

CD79b antibody (biotin)

61R-CD79bbMSBT 500 ug
EUR 479
Description: Hamster monoclonal CD79b antibody (biotin)

CD79B Antibody (Biotin)

20-abx312631
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

CD79B cloning plasmid

CSB-CL004958HU1-10ug 10ug
EUR 279.6
Description: A cloning plasmid for the CD79B gene.

CD79B cloning plasmid

CSB-CL004958HU2-10ug 10ug
EUR 279.6
Description: A cloning plasmid for the CD79B gene.

CD79B Blocking Peptide

DF6767-BP 1mg
EUR 234

CD79B Blocking Peptide

AF4649-BP 1mg
EUR 234

CD79b Blocking Peptide

20-abx161330
  • Ask for price
  • Ask for price
  • 1 mg
  • 5 mg

CD79b Blocking Peptide

20-abx161331
  • Ask for price
  • Ask for price
  • 1 mg
  • 5 mg

CD79B, human recombinant

7318-50 each
EUR 438

CD79B Human Recombinant

rAP-0059 Inquiry Ask for price

CD79b Polyclonal Antibody

41662 100ul
EUR 319

CD79b Polyclonal Antibody

41662-100ul 100ul
EUR 302.4

CD79b Polyclonal Antibody

41662-50ul 50ul
EUR 224.4

CD79b Polyclonal Antibody

E041662 100μg/100μl
EUR 255
Description: Available in various conjugation types.

CD79B Recombinant Protein

E43CP0228 500ug
EUR 580

CD79b Polyclonal Antibody

E20-75255 100ug
EUR 225
Description: Available in various conjugation types.

CD79b Polyclonal Antibody

ABP52986-003ml 0.03ml
EUR 189.6
Description: A polyclonal antibody for detection of CD79b from Human. This CD79b antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human CD79b

CD79b Polyclonal Antibody

ABP52986-01ml 0.1ml
EUR 346.8
Description: A polyclonal antibody for detection of CD79b from Human. This CD79b antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human CD79b

CD79b Polyclonal Antibody

ABP52986-02ml 0.2ml
EUR 496.8
Description: A polyclonal antibody for detection of CD79b from Human. This CD79b antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human CD79b

CD79B Recombinant Protein

91-738 0.05 mg
EUR 821.4
Description: CD79B is a single-pass type I membrane protein. CD79B contains one Ig-like V-type domain and one ITAM domain. CD79B is required in cooperation with CD79A for initiation of the signal transduction cascade activated by the B-cell antigen receptor complex (BCR), which leads to internalization of the complex, trafficking to late endosomes and antigen presentation. CD79B enhances phosphorylation of CD79A, possibly by recruiting kinases that phosphorylate CD79A or by recruiting proteins that bind to CD79A and protect it from dephosphorylation.

CD79b Polyclonal Antibody

E44H06697 100ul
EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

CD79B Polyclonal Antibody

E-AB-67397-120uL 120uL
EUR 320
Description: Unconjugated

CD79B Polyclonal Antibody

E-AB-67397-200uL 200uL
EUR 530
Description: Unconjugated

CD79B Polyclonal Antibody

E-AB-67397-60uL 60uL
EUR 200
Description: Unconjugated

CD79B Polyclonal Antibody

E-AB-67397-each each Ask for price
Description: Unconjugated

Lenti ORF clone of Cd79b (mGFP-tagged ORF) - Rat Cd79b molecule, immunoglobulin-associated beta (Cd79b), (10 ug)

RR207564L4 10 µg Ask for price

Anti-Ms CD79b PE

1P-584-C025 0.025 mg
EUR 88

Anti-Ms CD79b PE

1P-584-C100 0.1 mg
EUR 176

Anti-Hu CD79b PE

1P-676-T025 25 tests
EUR 121

Anti-Hu CD79b PE

1P-676-T100 100 tests
EUR 242

Lenti ORF clone of Cd79b (Myc-DDK-tagged ORF) - Rat Cd79b molecule, immunoglobulin-associated beta (Cd79b), (10 ug)

RR207564L3 10 µg Ask for price

Anti-Hu CD79b APC

1A-676-T025 25 tests
EUR 121

Anti-Hu CD79b APC

1A-676-T100 100 tests
EUR 242

Lenti-ORF clone of CD79B (mGFP-tagged)-Human CD79b molecule, immunoglobulin-associated beta (CD79B), transcript variant 2

RC217693L4 10 µg Ask for price

Lenti ORF particles, Cd79b (GFP-tagged ORF) - Rat Cd79b molecule, immunoglobulin-associated beta (Cd79b), 200ul, >10^7 TU/mL

RR207564L4V 200 µl Ask for price

Anti-Ms CD79b FITC

1F-584-C100 0.1 mg
EUR 154

Anti-Hu CD79b FITC

1F-676-T025 25 tests
EUR 99

Anti-Hu CD79b FITC

1F-676-T100 100 tests
EUR 198

Mouse Cd79b ELISA KIT

ELI-25434m 96 Tests
EUR 1038

Human CD79B ELISA KIT

ELI-34173h 96 Tests
EUR 988.8

CD79B protein (His tag)

80R-2614 100 ug
EUR 329
Description: Purified recombinant CD79B protein

CD79B Rabbit PolymAb®

A22465 20μL
EUR 1557.4
Description: Recombinant fusion protein containing a sequence corresponding to amino acids 1-150 of human GSDMC (NP_113603.1).

Anti-Ms CD79b Purified

11-584-C100 0.1 mg
EUR 132

Anti-Hu CD79b Purified

11-676-C025 0.025 mg
EUR 71.5

Anti-Hu CD79b Purified

11-676-C100 0.1 mg
EUR 143

CD79b/B29 Human, Antibody

GWB-A40D3B 0.1 mg Ask for price

Mouse CD79b Antibody (RPE)

GWB-EE3775 100 TESTS Ask for price

Mouse CD79b Antibody (RPE)

GWB-EE6730 25 TESTS Ask for price

CD79b antibody [HM79-11]

GWB-CD79B1 0.5 mg Ask for price

Lenti-ORF clone of CD79B (Myc-DDK-tagged)-Human CD79b molecule, immunoglobulin-associated beta (CD79B), transcript variant 2

RC217693L3 10 µg Ask for price

CD79b antibody (Azide Free)

10R-CD79bbMSP 500 ug
EUR 495
Description: Hamster monoclonal CD79b antibody (Azide Free)

Mouse CD79b Antibody (FITC)

GWB-28DA06 0.1 mg Ask for price

Mouse CD79b Antibody (FITC)

GWB-5C50EC 0.1 mg Ask for price

Human CD79B shRNA Plasmid

20-abx950695
  • Ask for price
  • Ask for price
  • 150 µg
  • 300 µg

Mouse CD79B shRNA Plasmid

20-abx970984
  • Ask for price
  • Ask for price
  • 150 µg
  • 300 µg

Mouse CD79b Antibody (FITC)

GWB-ACA5F4 0.02 mg Ask for price

Mouse CD79b Antibody (FITC)

GWB-911E60 0.5 mg Ask for price

Mouse CD79b Antibody (FITC)

GWB-C5EA40 0.02 mg Ask for price

Lenti ORF particles, Cd79b (Myc-DDK-tagged ORF) - Rat Cd79b molecule, immunoglobulin-associated beta (Cd79b), 200ul, >10^7 TU/mL

RR207564L3V 200 µl Ask for price

CD79B Human Recombinant, Sf9

rAP-0060 Inquiry Ask for price

CD79B Antibody, HRP conjugated

1-CSB-PA004958LB01HU
  • Ask for price
  • Ask for price
  • 100ug
  • 50ug
Description: A polyclonal antibody against CD79B. Recognizes CD79B from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

CD79B Recombinant Protein (Rat)

RP194027 100 ug Ask for price

CD79B Antibody, FITC conjugated

1-CSB-PA004958LC01HU
  • Ask for price
  • Ask for price
  • 100ug
  • 50ug
Description: A polyclonal antibody against CD79B. Recognizes CD79B from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

OACD04474-1ML - CD79B Antibody

OACD04474-1ML 1ml
EUR 639

OACD04475-1ML - CD79B Antibody

OACD04475-1ML 1ml
EUR 659

Throughout the text we highlight the advantages and disadvantages of each methodology and discuss the most promising developments in their path from bench to bedside.

Leave A Comment